• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

他克莫司通过抑制 NFATc1/TRPC6 通路改善糖尿病肾病的肾小管间质炎症。

Tacrolimus ameliorates tubulointerstitial inflammation in diabetic nephropathy via inhibiting the NFATc1/TRPC6 pathway.

机构信息

Department of Nephrology, The Second Xiangya Hospital, Central South University, Changsha, China.

出版信息

J Cell Mol Med. 2020 Sep;24(17):9810-9824. doi: 10.1111/jcmm.15562. Epub 2020 Aug 11.

DOI:10.1111/jcmm.15562
PMID:32779844
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7520323/
Abstract

Tubulointerstitial inflammation is crucial for the progression of diabetic nephropathy (DN), and tubular cells act as a driving force in the inflammatory cascade. Emerging data suggested that tacrolimus (TAC) ameliorates podocyte injury and macrophage infiltration in streptozotocin (STZ) mice. However, the effect of TAC on tubulointerstitial inflammation remains unknown. We found that albuminuria and tubulointerstitial damage improved in db/db mice treated with TAC. Macrophage infiltration and expression of IL-6, TNF-α, fibronectin, collagen 1 and cleaved caspase 3 were inhibited as well. In addition, the expression of nuclear factor of activated T cell 1 (NFATc1) and transient receptor potential channel 6 (TRPC6) was up-regulated in the kidneys of DN patients and correlated with tubular injury and inflammation. The expression of NFATc1 and TRPC6 also increased in the kidneys of db/db mice and HK-2 cells with high glucose (HG), while TAC inhibited these effects. HG-induced inflammatory markers and apoptosis were reversed by TAC and NFATc1 siRNA in HK-2 cells, which was abolished by TRPC6 plasmid. Furthermore, HG-induced TRPC6 expression was inhibited by NFATc1 siRNA, while NFATc1 nuclear translocation was inhibited by TAC, but was restored by TRPC6 plasmid in HK-2 cells under HG conditions. These findings suggest that TAC ameliorates tubulointerstitial inflammation in DN through NFATc1/TRPC6 feedback loop.

摘要

肾小管间质炎症对于糖尿病肾病(DN)的进展至关重要,而肾小管细胞在炎症级联反应中起驱动作用。新出现的数据表明,他克莫司(TAC)可改善链脲佐菌素(STZ)诱导的小鼠足细胞损伤和巨噬细胞浸润。然而,TAC 对肾小管间质炎症的影响尚不清楚。我们发现 TAC 治疗可改善 db/db 小鼠的蛋白尿和肾小管间质损伤。巨噬细胞浸润和 IL-6、TNF-α、纤维连接蛋白、胶原 1 和 cleaved caspase 3 的表达也受到抑制。此外,DN 患者肾脏中核因子活化 T 细胞 1(NFATc1)和瞬时受体电位通道 6(TRPC6)的表达上调,与肾小管损伤和炎症相关。db/db 小鼠肾脏和高糖(HG)培养的 HK-2 细胞中 NFATc1 和 TRPC6 的表达也增加,而 TAC 抑制了这些作用。TAC 和 NFATc1 siRNA 可逆转 HK-2 细胞中 HG 诱导的炎症标志物和细胞凋亡,而 TRPC6 质粒则消除了这种作用。此外,HG 诱导的 TRPC6 表达被 NFATc1 siRNA 抑制,而 TAC 抑制 NFATc1 核转位,但在 HG 条件下 HK-2 细胞中的 TRPC6 质粒则恢复了 NFATc1 核转位。这些发现表明,TAC 通过 NFATc1/TRPC6 反馈环改善 DN 中的肾小管间质炎症。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e28f/7520323/720b0080737c/JCMM-24-9810-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e28f/7520323/5dce3a42c181/JCMM-24-9810-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e28f/7520323/ee3b8c7c5e41/JCMM-24-9810-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e28f/7520323/720b0080737c/JCMM-24-9810-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e28f/7520323/5dce3a42c181/JCMM-24-9810-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e28f/7520323/ee3b8c7c5e41/JCMM-24-9810-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e28f/7520323/720b0080737c/JCMM-24-9810-g004.jpg

相似文献

1
Tacrolimus ameliorates tubulointerstitial inflammation in diabetic nephropathy via inhibiting the NFATc1/TRPC6 pathway.他克莫司通过抑制 NFATc1/TRPC6 通路改善糖尿病肾病的肾小管间质炎症。
J Cell Mol Med. 2020 Sep;24(17):9810-9824. doi: 10.1111/jcmm.15562. Epub 2020 Aug 11.
2
Increased TRPC6 expression is associated with tubular epithelial cell proliferation and inflammation in diabetic nephropathy.TRPC6 表达增加与糖尿病肾病肾小管上皮细胞增殖和炎症有关。
Mol Immunol. 2018 Feb;94:75-81. doi: 10.1016/j.molimm.2017.12.014. Epub 2018 Jan 4.
3
Tacrolimus Protects Podocytes from Apoptosis via Downregulation of TRPC6 in Diabetic Nephropathy.他克莫司通过下调糖尿病肾病中 TRPC6 保护足细胞免于凋亡。
J Diabetes Res. 2021 May 20;2021:8832114. doi: 10.1155/2021/8832114. eCollection 2021.
4
Epac activation ameliorates tubulointerstitial inflammation in diabetic nephropathy.Epac 的激活可改善糖尿病肾病的肾小管间质炎症。
Acta Pharmacol Sin. 2022 Mar;43(3):659-671. doi: 10.1038/s41401-021-00689-2. Epub 2021 Jun 8.
5
FK506 ameliorates podocyte injury in type 2 diabetic nephropathy by down-regulating TRPC6 and NFAT expression.他克莫司通过下调瞬时受体电位通道蛋白6(TRPC6)和活化T细胞核因子(NFAT)的表达改善2型糖尿病肾病中的足细胞损伤。
Int J Clin Exp Pathol. 2015 Nov 1;8(11):14063-74. eCollection 2015.
6
Participation of the AngII/TRPC6/NFAT axis in the pathogenesis of podocyte injury in rats with type 2 diabetes.血管紧张素 II/TRPC6/NFAT 轴在 2 型糖尿病大鼠足细胞损伤发病机制中的作用。
Mol Med Rep. 2019 Mar;19(3):2421-2430. doi: 10.3892/mmr.2019.9871. Epub 2019 Jan 17.
7
Astragaloside IV prevents high glucose-induced podocyte apoptosis via downregulation of TRPC6.黄芪甲苷IV通过下调瞬时受体电位阳离子通道蛋白6(TRPC6)来预防高糖诱导的足细胞凋亡。
Mol Med Rep. 2016 Jun;13(6):5149-56. doi: 10.3892/mmr.2016.5167. Epub 2016 Apr 22.
8
NFAT2 inhibitor ameliorates diabetic nephropathy and podocyte injury in db/db mice.NFAT2抑制剂改善db/db小鼠的糖尿病肾病和足细胞损伤。
Br J Pharmacol. 2013 Sep;170(2):426-39. doi: 10.1111/bph.12292.
9
Wogonin Alleviates Kidney Tubular Epithelial Injury in Diabetic Nephropathy by Inhibiting PI3K/Akt/NF-κB Signaling Pathways.汉黄芩素通过抑制 PI3K/Akt/NF-κB 信号通路减轻糖尿病肾病肾小管上皮细胞损伤。
Drug Des Devel Ther. 2021 Jul 16;15:3131-3150. doi: 10.2147/DDDT.S310882. eCollection 2021.
10
Gq signaling causes glomerular injury by activating TRPC6.Gq信号传导通过激活TRPC6导致肾小球损伤。
J Clin Invest. 2015 May;125(5):1913-26. doi: 10.1172/JCI76767. Epub 2015 Apr 6.

引用本文的文献

1
Anti-Fibrotic Effect of Tacrolimus on Preventing Adhesion after Achilles Tendon Surgery in a Murine Model.他克莫司对小鼠跟腱手术后预防粘连的抗纤维化作用
Iran J Med Sci. 2025 Aug 1;50(8):570-580. doi: 10.30476/ijms.2025.102711.3587. eCollection 2025 Aug.
2
Unlocking the therapeutic potential of the NFAT pathway in kidney diseases.释放NFAT信号通路在肾脏疾病中的治疗潜力。
Naunyn Schmiedebergs Arch Pharmacol. 2025 Mar 15. doi: 10.1007/s00210-025-04033-x.
3
PIEZO1-Mediated Calcium Signaling and Podocyte Injury in Diabetic Kidney Disease.

本文引用的文献

1
DsbA-L ameliorates high glucose induced tubular damage through maintaining MAM integrity.Dsba-L 通过维持 MAM 完整性改善高糖诱导的肾小管损伤。
EBioMedicine. 2019 May;43:607-619. doi: 10.1016/j.ebiom.2019.04.044. Epub 2019 May 3.
2
WNK1 promotes renal tumor progression by activating TRPC6-NFAT pathway.WNK1 通过激活 TRPC6-NFAT 通路促进肾肿瘤进展。
FASEB J. 2019 Jul;33(7):8588-8599. doi: 10.1096/fj.201802019RR. Epub 2019 Apr 25.
3
Efficacy and safety of tacrolimus in induction therapy of patients with lupus nephritis.
Piezo1介导的钙信号传导与糖尿病肾病中的足细胞损伤
J Am Soc Nephrol. 2025 Feb 11;36(7):1310-1326. doi: 10.1681/ASN.0000000634.
4
Tacrolimus and diabetic rodent models.他克莫司与糖尿病啮齿动物模型。
Pharmacol Rep. 2025 Apr;77(2):333-354. doi: 10.1007/s43440-024-00693-3. Epub 2025 Jan 21.
5
TRPC6-Calpain-1 Axis Promotes Tubulointerstitial Inflammation by Inhibiting Mitophagy in Diabetic Kidney Disease.TRPC6-钙蛋白酶-1轴通过抑制糖尿病肾病中的线粒体自噬促进肾小管间质炎症。
Kidney Int Rep. 2024 Aug 23;9(11):3301-3317. doi: 10.1016/j.ekir.2024.08.019. eCollection 2024 Nov.
6
The roles of TRPC6 in renal tubular disorders: a narrative review.TRPC6 在肾小管疾病中的作用:叙述性综述。
Ren Fail. 2024 Dec;46(2):2376929. doi: 10.1080/0886022X.2024.2376929. Epub 2024 Jul 18.
7
Rituximab Combined with Steroid and Tacrolimus Treats Proliferative Glomerulonephritis with Monoclonal IgG Deposits: A Case Report and Review of the Literature.利妥昔单抗联合激素和他克莫司治疗伴有单克隆 IgG 沉积的增殖性肾小球肾炎:病例报告及文献复习。
Curr Med Chem. 2024;31(41):6902-6908. doi: 10.2174/0109298673272183240108093135.
8
A Putative Role for TRPC6 in Immune-Mediated Kidney Injury.TRPC6 在免疫介导的肾脏损伤中的推测作用。
Int J Mol Sci. 2023 Nov 16;24(22):16419. doi: 10.3390/ijms242216419.
9
Cordycepin from Cordyceps militaris ameliorates diabetic nephropathy via the miR-193b-5p/MCL-1 axis.来自蛹虫草的虫草素通过miR-193b-5p/MCL-1轴改善糖尿病肾病。
Chin Med. 2023 Oct 13;18(1):134. doi: 10.1186/s13020-023-00842-5.
10
NETosis: an emerging therapeutic target in renal diseases.中性粒细胞胞外诱捕网:肾脏疾病治疗的新靶点
Front Immunol. 2023 Sep 8;14:1253667. doi: 10.3389/fimmu.2023.1253667. eCollection 2023.
他克莫司在狼疮性肾炎患者诱导治疗中的疗效与安全性。
Drug Des Devel Ther. 2019 Mar 12;13:857-869. doi: 10.2147/DDDT.S189156. eCollection 2019.
4
Disulfide-bond A oxidoreductase-like protein protects against ectopic fat deposition and lipid-related kidney damage in diabetic nephropathy.二硫键 A 氧化还原酶样蛋白可防止糖尿病肾病中外溢性脂肪沉积和与脂质相关的肾脏损伤。
Kidney Int. 2019 Apr;95(4):880-895. doi: 10.1016/j.kint.2018.10.038. Epub 2019 Feb 18.
5
Knockout of TRPC6 promotes insulin resistance and exacerbates glomerular injury in Akita mice.TRPC6 敲除可促进 Akita 小鼠胰岛素抵抗并加重肾小球损伤。
Kidney Int. 2019 Feb;95(2):321-332. doi: 10.1016/j.kint.2018.09.026.
6
Safety and efficacy of patiromer use with tacrolimus in kidney transplant recipients.帕替罗姆与他克莫司联合用于肾移植受者的安全性和有效性。
Transpl Int. 2019 Jan;32(1):110-111. doi: 10.1111/tri.13369. Epub 2018 Nov 15.
7
The calcineurin regulatory subunit polymorphism and the treatment efficacy of tacrolimus for idiopathic membranous nephropathy.钙调磷酸酶调节亚基多态性与他克莫司治疗特发性膜性肾病的疗效。
Int Immunopharmacol. 2018 Dec;65:422-428. doi: 10.1016/j.intimp.2018.10.038. Epub 2018 Oct 30.
8
Ectopic lipid accumulation: potential role in tubular injury and inflammation in diabetic kidney disease.异位脂质积累:在糖尿病肾病的管状损伤和炎症中的潜在作用。
Clin Sci (Lond). 2018 Nov 21;132(22):2407-2422. doi: 10.1042/CS20180702. Print 2018 Nov 30.
9
miR-374a Regulates Inflammatory Response in Diabetic Nephropathy by Targeting MCP-1 Expression.miR-374a通过靶向MCP-1表达调控糖尿病肾病中的炎症反应。
Front Pharmacol. 2018 Aug 10;9:900. doi: 10.3389/fphar.2018.00900. eCollection 2018.
10
A NOX4/TRPC6 Pathway in Podocyte Calcium Regulation and Renal Damage in Diabetic Kidney Disease.足细胞钙调节和糖尿病肾病肾损伤中的 NOX4/TRPC6 通路。
J Am Soc Nephrol. 2018 Jul;29(7):1917-1927. doi: 10.1681/ASN.2018030280. Epub 2018 May 23.